Does a novel diagnostic pathway including blood-based risk prediction and MRI-targeted biopsies outperform prostate cancer screening using prostate-specific antigen and systematic prostate biopsies? - protocol of the randomised study STHLM3MRI

INTRODUCTION: Prostate cancer is a leading cause of cancer death among men in the Western world. Early detection of prostate cancer has been shown to decrease mortality, but has limitations with low specificity leading to unnecessary biopsies and overdiagnosis of low-risk cancers. The STHLM3 trial h...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMJ Open
Main Authors: Nordström, Tobias, Jäderling, Fredrik, Carlsson, Stefan, Aly, Markus, Grönberg, Henrik, Eklund, Martin
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2019
Assuntos:
Urology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6576112/
https://ncbi.nlm.nih.gov/pubmed/31201191
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2018-027816
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados